-
Mashup Score: 1
Patients with chronic spontaneous urticaria (CSU) have spontaneous wheals (W), angioedema (AE), or both, for longer than 6 weeks. Clinical differences between patients with standalone W, standalone AE, and W and AE (W+AE) remain incompletely understood.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Similar response to omalizumab in children with allergic asthma from different racial backgrounds - 7 month(s) ago
Racial and ethnic minority populations in the United States, especially Black children, endure an increased burden of asthma due to factors such as environmental exposure, access to health care, and genetics.1 Compared with White children, Black children with asthma experience reduced quality of life, have more poorly controlled disease, require longer-term corticosteroid use, and are more frequently evaluated in emergency department visits.1 In addition, Black children are 3 times as likely to be hospitalized and 7 times as likely to die from asthma as White children.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Similar #response to #omalizumab in #children with #allergic #asthma from different #racial #backgrounds https://t.co/62vGNMKQoJ https://t.co/zDVu39ioY6
-
-
Mashup Score: 1Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis - 8 month(s) ago
Omalizumab is the only biological agent approved for patients with chronic spontaneous urticaria (CSU), but no biomarker is well established for predicting clinical response to omalizumab.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Association Between #Serum Total IgE Levels and #Clinical #Response to #Omalizumab for #Chronic #Spontaneous #Urticaria: A Systematic #Review and Meta- #Analysis https://t.co/8FwYKKExhK https://t.co/m4fLvwXtpK
-
-
Mashup Score: 0
Background Mortality prediction for intensive care unit (ICU) patients frequently relies on single acuity measures based on ICU admission physiology without accounting for subsequent clinical changes. Objectives Evaluate novel models incorporating modified admission and daily, time-updating Laboratory-based Acute Physiology Scores, version 2 (LAPS2) to predict in-hospital mortality among ICU…
Source: medRxivCategories: Latest Headlines, PulmonologyTweet-
#Immune #response to the #mRNA #COVID-19 #vaccine in #hemodialysis #patients: cohort study https://t.co/ShAXCACFQ7 https://t.co/krrdydFSH8
-
-
Mashup Score: 0Yes, donor-recipient sex is associated with transfusion-related outcomes in critically ill patients - 1 year(s) ago
TO THE EDITOR:
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Yes, donor-recipient sex is associated with transfusion-related outcomes in critically ill patients https://t.co/d2OqC5oLJL #response #transfusionmedicine
-
-
Mashup Score: 0Reply to “Improvements in asthma control and quality of life with benralizumab are unrelated to baseline bronchodilator response” - 1 year(s) ago
We thank Chan et al1 for their comment on our recent article.2 In our retrospective registry analysis, we found that the presence or absence of bronchodilator responsiveness (BDR) at baseline was unrelated to the outcome of anti-IL5/anti-IL5Rα treatment, that is, improvements of exacerbations, steroid use, asthma control, and forced expiratory volume in 1 second (FEV1) were similar in both…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Reply to “Improvements in #asthma #control and #quality of #life with #benralizumab are unrelated to #baseline #bronchodilator #response” https://t.co/IB0NwetbP3
-
-
Mashup Score: 0
Inappropriate accumulation of alveolar macrophages (AMs) and subsequent excessive production of immune responses play critical roles in the pathogenesis of acute lung injury (ALI), but the core negative regulators governing innate signaling in AMs are ill defined. We have previously shown that singl …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
Regulation of CD18 stability by SIGIRR-modulated ubiquitination: New insights into the relationship between #innate #immune #response and #acute #lung #injury https://t.co/tlVfkFia8C https://t.co/U95U9rIPb6
-
-
Mashup Score: 1
Objective This retrospective analysis evaluated the prognostic value of renal response status 2 years after biopsy-proven lupus nephritis (LN) for the prediction of long-term renal outcomes. Methods Eligible patients with SLE as per American College of Rheumatology or Systemic Lupus International Collaborating Clinics criteria and biopsy-proven class III, IV, V or mixed LN were identified from…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet-
Achieving a modified #primary efficacy #renal #response is significantly associated with better long-term renal #survival and #chronic renal #insufficiency-free survival in #patients with #LN. #SLE #Lupus https://t.co/7F9o118Nk3
-
-
Mashup Score: 0
Objective This retrospective analysis evaluated the prognostic value of renal response status 2 years after biopsy-proven lupus nephritis (LN) for the prediction of long-term renal outcomes. Methods Eligible patients with SLE as per American College of Rheumatology or Systemic Lupus International Collaborating Clinics criteria and biopsy-proven class III, IV, V or mixed LN were identified from…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet-
Achieving a modified #primary efficacy #renal #response is significantly associated with better long-term renal #survival and #chronic renal #insufficiency-free survival in #patients with #LN. #SLE #Lupus https://t.co/7F9o118Nk3
-
-
Mashup Score: 0
Objectives To evaluate the safety and immunogenicity of third and fourth BNT162b2 boosters in patients with SLE and rheumatoid arthritis (RA). Methods Patients with SLE and RA aged 18–65 years who completed a series of inactivated, adenoviral vector, or heterogenous adenoviral vector/mRNA vaccines for at least 28 days were enrolled. Immunogenicity assessment was done before and day 15 after each…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet-
#Epidemiology This week on LSM: Third #BNT162b2 #booster significantly improved #humoral & #cellular #immunogenicity in patients with #SLE & #RA. The #benefit of a short-interval fourth booster in #patients with #suboptimal #humoral #response was unclear https://t.co/A67fzCDgEg
-
In Press! #Patients With #Chronic #Spontaneous #Urticaria Who Have #Wheals, #Angioedema, or Both, Differ #Demographically, #Clinically, and in #Response to #Treatment— #Results From CURE https://t.co/vTsthjkW1k https://t.co/XcFjr5ndwc